02|20|25

Building Trust With Education and Innovation: Rare Disease Marketing

Rare and ultra-rare diseases face problems most brands do … turned up to 11. Budgets? Smaller. Patient pool? Even smaller. Healthcare providers (HCPs) who understand the condition? Sometimes even smaller than that. Treatment options can be limited, access can be hard to find and diagnosis time can sometimes be measured in decades rather than months. […]

02|10|25

Next-Generation Brand Planning: (Unexpected) Worrying Trends Demand a Rethink on Brand Planning

In our third annual report on the state of brand planning, EVERSANA surveyed nearly 100 brand planning executives across biopharmaceuticals, diagnostics and medical devices. This year, we expanded our assessment by hosting 111 marketing leaders from around the globe at a client advisory board in Napa Valley, California, to hear firsthand about key advancements and persistent challenges in brand planning. Download the POV to learn more.

02|06|25

Pharma Marketing and the Super Bowl: A Missed Opportunity?

During the Super Bowl, is when we see some of the most entertaining and memorable commercials. However, pharmaceutical companies often remain on the sidelines during this prime advertising opportunity. In a recent article in MM+M, pharma industry thought leaders, including John Kenny, Chief Strategy Officer, and Susan Perlbachs, Chief Creative Officer, offer their insights as to why pharma brands are hesitant to invest in Super Bowl ads despite the massive audience.

01|30|25

The Power of Data and Machine Learning to Optimize HCP Prescription Volume

In a recently published article from Med Ad News, co-authors Iyiola Obayomi, SVP, Managing Director, Data & Analytics, at EVERSANA INTOUCH, and Pierantonio Russo, MD, FCPP, FAAP, STS, Chief Medical Officer at EVERSANA, discuss the power of data and analytics and machine learning (ML) to optimize HCP targeting and prescription volume.

01|28|25

Pharma Marketing in 2025: Talking Trends With Angela Tenuta

In a rapidly evolving industry, staying ahead of the curve is critical. In PM360's article, “What Is Pharma Marketing in 2025?” Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. Read the blog to learn more.

01|24|25

Creating Award-Winning Work: Insights From Susan Perlbachs With Muse by Clios

In a recent interview with Muse by Clios, Susan Perlbachs, Chief Creative Officer, offered profound insights into the ever-changing world of healthcare advertising. Dive into our blog to discover the secrets behind creating award-winning campaigns and explore inspiring examples.

01|21|25

2025 Data Privacy Landscape: Is Pharma Ready for the Scrutiny?

The data privacy landscape in 2025 presents new risks for pharmaceutical companies due to a surge in state-specific privacy laws in the U.S., evolving global regulations and increased scrutiny of artificial intelligence (AI) technologies. Today, compliance is essential for maintaining consumer trust, protecting sensitive health data and avoiding regulatory penalties. Access the POV to learn how your brand can prepare for the changes in the 2025 data privacy landscape.

01|17|25

Unlocking Market Advantage Through Medical Communications

In a recent article published by Med Ad News, Mary Anderson, Senior VP, Managing Director and Head of MedComm at EVERSANA INTOUCH, highlighted the pivotal role medical communications (MedComm) has played in giving brands a leg up in a competitive market. Read the blog to learn more.

01|15|25

Creative Revolution and the Future of AI: Insights from Adobe MAX Part 2 

In part two of insights from Adobe MAX, Susan Perlbachs, Chief Creative Officer, offered valuable insights into the future of creatives in this era of AI. Through a series of short interviews, she discussed how generative AI tools are transforming creative teams, operations and content creation. Read the blog to learn more.

01|13|25

Embracing Creativity and Technology: Insights from Adobe MAX Part 1

At EVERSANA INTOUCH, Artful Ingenuity drives our success by blending human creativity with innovative technology and data insights. Chief Creative Officer Susan Perlbachs highlighted this at Adobe MAX, emphasizing the importance of adapting operations, fostering purpose-driven creativity, and building future-ready design teams. These strategies ensure creativity flourishes alongside technological advancements.